These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 16840721)
1. Endoglin regulates cyclooxygenase-2 expression and activity. Jerkic M; Rivas-Elena JV; Santibanez JF; Prieto M; Rodríguez-Barbero A; Perez-Barriocanal F; Pericacho M; Arévalo M; Vary CP; Letarte M; Bernabeu C; López-Novoa JM Circ Res; 2006 Aug; 99(3):248-56. PubMed ID: 16840721 [TBL] [Abstract][Full Text] [Related]
2. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Toporsian M; Gros R; Kabir MG; Vera S; Govindaraju K; Eidelman DH; Husain M; Letarte M Circ Res; 2005 Apr; 96(6):684-92. PubMed ID: 15718503 [TBL] [Abstract][Full Text] [Related]
4. Spontaneous adult-onset pulmonary arterial hypertension attributable to increased endothelial oxidative stress in a murine model of hereditary hemorrhagic telangiectasia. Toporsian M; Jerkic M; Zhou YQ; Kabir MG; Yu LX; McIntyre BA; Davis A; Wang YJ; Stewart DJ; Belik J; Husain M; Henkelman M; Letarte M Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):509-17. PubMed ID: 20042709 [TBL] [Abstract][Full Text] [Related]
6. Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling. Santibanez JF; Letamendia A; Perez-Barriocanal F; Silvestri C; Saura M; Vary CP; Lopez-Novoa JM; Attisano L; Bernabeu C J Cell Physiol; 2007 Feb; 210(2):456-68. PubMed ID: 17058229 [TBL] [Abstract][Full Text] [Related]
7. Reduced angiogenic responses in adult Endoglin heterozygous mice. Jerkic M; Rodríguez-Barbero A; Prieto M; Toporsian M; Pericacho M; Rivas-Elena JV; Obreo J; Wang A; Pérez-Barriocanal F; Arévalo M; Bernabéu C; Letarte M; López-Novoa JM Cardiovasc Res; 2006 Mar; 69(4):845-54. PubMed ID: 16405930 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750 [TBL] [Abstract][Full Text] [Related]
9. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway. Pece-Barbara N; Vera S; Kathirkamathamby K; Liebner S; Di Guglielmo GM; Dejana E; Wrana JL; Letarte M J Biol Chem; 2005 Jul; 280(30):27800-8. PubMed ID: 15923183 [TBL] [Abstract][Full Text] [Related]
10. Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-β signaling pathways. Park S; Dimaio TA; Liu W; Wang S; Sorenson CM; Sheibani N J Cell Sci; 2013 Mar; 126(Pt 6):1392-405. PubMed ID: 23418351 [TBL] [Abstract][Full Text] [Related]
11. Oxidative stress contributes to endothelial dysfunction in mouse models of hereditary hemorrhagic telangiectasia. Jerkic M; Sotov V; Letarte M Oxid Med Cell Longev; 2012; 2012():686972. PubMed ID: 23320130 [TBL] [Abstract][Full Text] [Related]
13. Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice. Düwel A; Eleno N; Jerkic M; Arevalo M; Bolaños JP; Bernabeu C; López-Novoa JM Tumour Biol; 2007; 28(1):1-8. PubMed ID: 17108712 [TBL] [Abstract][Full Text] [Related]
14. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1. Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823 [TBL] [Abstract][Full Text] [Related]
15. Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. Bourdeau A; Faughnan ME; McDonald ML; Paterson AD; Wanless IR; Letarte M Am J Pathol; 2001 Jun; 158(6):2011-20. PubMed ID: 11395379 [TBL] [Abstract][Full Text] [Related]
16. Endoglin in angiogenesis and vascular diseases. ten Dijke P; Goumans MJ; Pardali E Angiogenesis; 2008; 11(1):79-89. PubMed ID: 18283546 [TBL] [Abstract][Full Text] [Related]
17. Age-dependent endothelial nitric oxide synthase uncoupling in pulmonary arteries of endoglin heterozygous mice. Belik J; Jerkic M; McIntyre BA; Pan J; Leen J; Yu LX; Henkelman RM; Toporsian M; Letarte M Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1170-8. PubMed ID: 19820034 [TBL] [Abstract][Full Text] [Related]
18. Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment. Ardelean DS; Jerkic M; Yin M; Peter M; Ngan B; Kerbel RS; Foster FS; Letarte M Angiogenesis; 2014 Jan; 17(1):129-46. PubMed ID: 24061911 [TBL] [Abstract][Full Text] [Related]
19. Increased endothelial cell permeability in endoglin-deficient cells. Jerkic M; Letarte M FASEB J; 2015 Sep; 29(9):3678-88. PubMed ID: 25972355 [TBL] [Abstract][Full Text] [Related]
20. Endoglin upregulation during experimental renal interstitial fibrosis in mice. Rodríguez-Peña A; Eleno N; Düwell A; Arévalo M; Pérez-Barriocanal F; Flores O; Docherty N; Bernabeu C; Letarte M; López-Novoa JM Hypertension; 2002 Nov; 40(5):713-20. PubMed ID: 12411467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]